Cargando…
Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214095/ https://www.ncbi.nlm.nih.gov/pubmed/37218500 http://dx.doi.org/10.1042/BSR-2019-2800_EOC |
| _version_ | 1785047764960280576 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10214095 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Portland Press Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102140952023-05-27 Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation Biosci Rep Expression of Concern Portland Press Ltd. 2023-05-23 /pmc/articles/PMC10214095/ /pubmed/37218500 http://dx.doi.org/10.1042/BSR-2019-2800_EOC Text en © 2023 The Author(s). https://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Expression of Concern Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation |
| title | Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation |
| title_full | Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation |
| title_fullStr | Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation |
| title_full_unstemmed | Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation |
| title_short | Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation |
| title_sort | expression of concern: atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced m1 microglial activation |
| topic | Expression of Concern |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214095/ https://www.ncbi.nlm.nih.gov/pubmed/37218500 http://dx.doi.org/10.1042/BSR-2019-2800_EOC |